共 50 条
- [31] RAINIER: A randomized, double-blinded, placebo-controlled phase II trial of gemcitabine (gem) plus nab-paclitaxel (nab-P) combined with apatorsen (A) or placebo (Pl) in patients (pts) with metastatic pancreatic cancer (mPC).JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)Ko, Andrew H.Murphy, Patrick B.Peyton, James D.Shipley, DiannaAl-Hazzouri, AhmedRodriguez, Frank A.Womack, Mark S.Xiong, Henry Q.Waterhouse, David M.Tempero, Margaret A.Bendell, Johanna C.
- [32] A randomized, multicenter, double-blind, placebo-controlled study of the Bruton tyrosine kinase inhibitor, ibrutinib, versus placebo in combination with nab-paclitaxel and gemcitabine in the first-line treatment of patients with metastatic pancreatic adenocarcinoma (RESOLVE).JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)Tempero, Margaret A.Coussens, Lisa M.Fong, LawrenceManges, RobertSingh, PriyankaLi, YunfengCole, George W.James, Danelle FrancesTabernero, Josep
- [33] Delta tocotrienol as a supplement to FOLFOXIRI in first-line treatment of metastatic colorectal cancer. A randomized, double-blind, placebo-controlled phase II studyACTA ONCOLOGICA, 2023, 62 (09) : 1066 - 1075Raunkilde, LouiseHansen, Torben FrostrupHavelund, Birgitte MaylandThomsen, Caroline BrennerRafaelsen, Soren RafaelLindebjerg, JanJensen, Lars Henrik
- [34] A Randomized, Double-blinded, Placebo-controlled, Multicenter, Efficacy and Safety Study of 3.75% Imiquimod Cream Following Cryosurgery for the Treatment of Actinic KeratosesJOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (09) : 1101 - 1108Jorizzo, Joseph L.Markowitz, OritLebwohl, Mark G.Bourcier, MarcKulp, JamesMeng, Tze-ChiangLevy, Sharon
- [35] Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer:a multicenter, randomized,double-blinded,placebo-controlled,phase Ⅱclinical trialChinese Journal of Cancer, 2017, 36 (12) : 677 - 685RuiHua XuLin ShenKeMing WangGang WuChunMei ShiKeFeng DingLiZhu LinJinWan WangJianPing XiongChangPing WuJin LiYunPeng LiuDong WangYi BaJuePing FengYuXian BaiJingWang BiLiWen MaJian LeiQing YangHao Yu
- [36] Efficacy and safety of rupatadine fumarate in the treatment of perennial allergic rhinitis: A multicenter, double-blinded, randomized, placebo-controlled, bridging study in KoreansASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2024, 42 (04): : 346 - 353Won, Tae-BinKim, Hyung GuKim, Jeong-WhunKim, Jin KookKim, Young HyoKim, Soo WhanKim, Hyo YeolKim, Dae WooKim, Sung WanKim, Chang-HoonRhee, Chae-Seo
- [37] Efficacy and safety of sintilimab combined nab-paclitaxel and gemcitabine as first-line treatment for metastatic pancreatic ductal adenocarcinoma (PDAC): A retrospective analysisANNALS OF ONCOLOGY, 2022, 33 : S247 - S247Wang, J.He, Y.Lv, H.Chen, B.Nie, C.Xu, W.Zhao, J.Zhang, B.Cheng, X.Li, Q.Tu, S.Chen, X.
- [38] Efficacy of mecasin for treatment of amyotrophic lateral sclerosis: A phase IIa multicenter randomized double-blinded placebo-controlled trialJOURNAL OF ETHNOPHARMACOLOGY, 2023, 315Kim, SunghaYang, MuhackKu, BonchoCha, EunhyeSeo, WookcheolSon, IlhongKang, HyungwonKim, DongwoungSong, BongkeunYang, Chang-SopKim, Sungchul
- [39] Efficacy and safety of plecanatide in Chinese patients with functional constipation: A phase III randomized, double-blinded, placebo-controlled, multicenter trialNEUROGASTROENTEROLOGY AND MOTILITY, 2024, 36Bai, TaoXu, ZhiyueJiang, YuepingZhao, HongYan, PengDai, NingChen, XiHuang, KunmingCui, JunXu, MinJia, ShujuanZhang, JuanLiu, SideLi, XiaoqingAi, YaoweiZhang, MingxinWu, YongdongZhou, WeizhenZhao, RongWu, JianjunWang, BangmaoXu, BaohongDing, XiangwuFang, XiangmingYang, ShaoqiMa, YingcaiZhou, ZhongyinLin, LinChen, HuixinZhang, HengZhu, YinJiang, BoZhang, XiaolanWang, XiaoyanZou, DuowuYe, BinZhang, LingShi, RuihuaZhen, YanboWang, JunpingLiu, YouliLiao, AijunHou, Xiaohua
- [40] Efficacy and safety of adrenomedullin for acute ischemic stroke (AMFIS): a phase 2, randomized, double-blinded, placebo-controlled, clinical trialECLINICALMEDICINE, 2024, 77Yoshimoto, TakeshiSaito, SatoshiOmae, KatsuhiroTanaka, KentaKita, ToshihiroKitamura, KazuoFukuma, KazukiWashida, KazuoAbe, SoichiroIshiyama, HiroyukiYamaguchi, ErikoYamagami, HiroshiNagatsuka, KazuyukiTsuji, MasahiroMinami, ManabuYamamoto, HarukoHattori, YoritoTanaka, TomotakaIhara, Masafumi